- Open Access
Commentary: setting priorities in NCD prevention and control
© Pan American Health Organization 2018
- Published: 9 November 2018
Decision making in health requires the use of sound evidence and context-specific information, guided by a priority setting methodology or framework. For noncommunicable disease (NCD) prevention and control, a decision-making methodology has been applied by the World Health Organization to delineate priorities, and options for cost-effective NCD interventions. A set of 14 interventions considered very cost-effective, affordable and feasible for implementation in various resource level settings were identified. Among them, tobacco control through taxation, bans on tobacco advertising, plain packaging, and smoke free public spaces stands out as perhaps the single most important interventions to tackle NCDs.
- Priority setting
- Noncommunicable diseases
- Cost effectiveness
Because of the sheer magnitude of the burden and impact of NCDs in all countries, it is urgent and important to make NCD prevention and control a health priority. However, making decisions on which public health interventions to prioritize, among the vast range of interventions needed to improve NCD prevention and control efforts is a challenge. The WHO NCD cost-effective interventions, which was developed using a priority setting methodology, provides a sound, technical list of priority interventions that are feasible and affordable to implement in various resource-level settings.
Authors’ contributions The authors are staff members of the Pan American Health Organization. The authors alone are responsible for the views expressed in this publication, and they do not necessarily represent the decisions or policies of the Pan American Health Organization. Both authors read and approved the final manuscript.
Availability of data and material
Consent for publication
Ethics approval and consent to participate
The publication costs for this article were funded by Mark O’Friel, the Brinson Foundation, and the Payne Family Foundation.
About this supplement
This article has been published as part of Cost Effectiveness and Resource Allocation Volume 16 Supplement 1, 2018: Priority Setting in Global Health. The full contents of the supplement are available online at https://resource-allocation.biomedcentral.com/articles/supplements/volume-16-supplement-1.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. In any reproduction of this article there should not be any suggestion that PAHO or this article endorse any specific Organization or products. The use of the PAHO logo is not permitted. This notice should be preserved along with the article’s original URL.
- Muka T, Imo D, Jaspers L, Colpani V, Chaker L, van der Lee SJ, Mendis S, Chowdhury R, Bramer WM, Falla A, Pazoki R, Franco OH. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol. 2015;30(4):251–77.View ArticleGoogle Scholar
- World Health Organization/World Economic Forum. From Burden to ‘’Best Buys’’: Reducing the economic impact of noncommunicable diseases in low- and middle-income countries. Geneva: World Economic Forum; Geneva. http://www.who.int/nmh/publications/best_buys_summary.pdf. Accessed 16 May 2017.
- Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, Feigl AB, Gaziano T, Mowafi M, Pandya A, Prettner K, Rosenberg L, Seligman B, Stein AZ, Weinstein C. 2011. The global economic burden of noncommunicable diseases. Geneva: World Economic Forum. http://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf. Accessed 16 May 2017.
- World Health Organization. Global Health Estimates from the global mortality database. 2017. http://www.who.int/healthinfo/global_burden_disease/projections/en/. Accessed 29 Aug 2017.
- Guindo LA, Wagner M, Baltussen R, Rindress D, van Til J, Kind P, Goetghebeur MM. From efficacy to equity: literature review of decision criteria for resource allocation and healthcare decisionmaking. Cost Eff Resour Alloc. 2012;10:9–13.View ArticleGoogle Scholar
- Goetghebeur M, Wagner M, Khoury H, Levitt R, Erickson L, Rindress D. Evidence and value: impact on DEcisionMaking—the EVIDEM framework and potential applications. BMC Health Serv Res. 2008;8:270–5.View ArticleGoogle Scholar
- World Health Organization. Making choices in Health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003.Google Scholar
- Gu Y, Lancsar E, Ghijben P, Butler JR, Donaldson C. Attributes and weights in health care priority setting: a systematic review of what counts and to what extent. Soc Sci Med. 2015;146:41–52.View ArticleGoogle Scholar
- Stenberg K, Chisholm D. Resource needs for addressing noncommunicable disease in low- and middle-income countries. Global Heart. 2012;7(1):53–60.View ArticleGoogle Scholar
- Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377:1438–47.View ArticleGoogle Scholar
- World Health Organization. Preparation for the third high-level meeting of the general assembly on the prevention and control of non-communicable diseases, to be held in 2018. Report by the Director General. 2016. http://apps.who.int/gb/ebwha/pdf_files/EB140/B140_27-en.pdf?ua=1. Accessed 16 May 2017.